Daniele Gianoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniele Gianoli has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Martens
Spine Center of Eastern Switzerland, Kantonsspital St. Gallen & Medical School of St. Gallen, St. Gallen, Switzerland
1 shared publication - Cyrill Dennler
Department of Orthopedics and Traumatology Cantonal Hospital St. Gallen, Switzerland
1 shared publication - Frederike Waldeck
Department of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, Switzerland
1 shared publication - Michal Ziga
Department of Neurosurgery, Cantonal Hospital St. Gallen, Switzerland
1 shared publication - Rainer Schlichtherle
Department of Orthopedics and Traumatology Cantonal Hospital St. Gallen, Switzerland
1 shared publication - Roman Schwizer
Department of Orthopedics and Traumatology Cantonal Hospital St. Gallen, Switzerland
1 shared publication
Latest Publications
- Open Access
- 30 September 2021
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 12, 496
Spondylodiscitis due to anaerobic bacteria Veillonella parvula: Case report and literature review
Background: While pyogenic spondylodiscitis due to Gram-positive aerobic bacteria and its treatment is well known, spondylodiscitis caused by anaerobic Gram-negative pathogen is rare. In particular, the spondylodiscitis caused by Veillonella species is an absolute rarity. Thus no established management recommendations exist. Case Description: A case report of a 79-year-old man with spondylodiscitis caused by Veillonella parvula with intramuscular abscess collection managed conservatively with stand-alone antibiotic therapy without a spinal stabilization procedure. A review of literature of all reported spondylodiscitis caused by Veillonella species was performed. After 3 week-intravenous therapy with the ceftriaxone in combination with the metronidazole followed by 3 weeks per oral therapy with amoxicillin/clavulanate, the complete recovery of the patient with the V. parvula infection was achieved. Conclusion: Treatment of the spondylodiscitis caused by Veillonella species should contain a beta-lactam with beta-lactamase inhibitor or third-generation cephalosporine. Six weeks of treatment seem to be sufficient for the complete recovery of the patient.
- 30 September 2021
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 12, 496
Open AccessSpondylodiscitis due to anaerobic bacteria Veillonella parvula: Case report and literature review
Background: While pyogenic spondylodiscitis due to Gram-positive aerobic bacteria and its treatment is well known, spondylodiscitis caused by anaerobic Gram-negative pathogen is rare. In particular, the spondylodiscitis caused by Veillonella species is an absolute rarity. Thus no established management recommendations exist. Case Description: A case report of a 79-year-old man with spondylodiscitis caused by Veillonella parvula with intramuscular abscess collection managed conservatively with stand-alone antibiotic therapy without a spinal stabilization procedure. A review of literature of all reported spondylodiscitis caused by Veillonella species was performed. After 3 week-intravenous therapy with the ceftriaxone in combination with the metronidazole followed by 3 weeks per oral therapy with amoxicillin/clavulanate, the complete recovery of the patient with the V. parvula infection was achieved. Conclusion: Treatment of the spondylodiscitis caused by Veillonella species should contain a beta-lactam with beta-lactamase inhibitor or third-generation cephalosporine. Six weeks of treatment seem to be sufficient for the complete recovery of the patient.